-
公开(公告)号:US20190024054A1
公开(公告)日:2019-01-24
申请号:US15769595
申请日:2016-10-20
发明人: Kenta YAMAMOTO , Tsunao KISHIDA , Yoshihiro SOWA , Toshiro YAMAMOTO , Osam MAZDA
IPC分类号: C12N5/077 , C12N5/0775
摘要: Provided is a method of preparing a somatic cell including converting a differentiated somatic cell of a mammal to other somatic cell by culturing the differentiated somatic cell in a medium for inducing differentiation of the somatic cell other than the differentiated somatic cell in the presence of a TGF-β pathway inhibitor.
-
公开(公告)号:US20180355319A1
公开(公告)日:2018-12-13
申请号:US15750285
申请日:2016-08-08
发明人: Kenta YAMAMOTO , Tsunao KISHIDA , Toshiro YAMAMOTO , Osam MAZDA
IPC分类号: C12N5/077
CPC分类号: C12N5/0653 , A61K35/35 , A61L27/00 , C12N2501/30 , C12N2501/999 , C12N2506/1307
摘要: The present invention aims to provide a brown adipocyte and a generation method thereof, a transplantation material containing a brown adipocyte, a prophylactic agent or therapeutic agent containing a brown adipocyte for various diseases and conditions, and use thereof. Provided is a method for generating a brown adipocyte, including converting a differentiated somatic cell of a mammal to a brown adipocyte by culturing the somatic cell in a medium in the presence of at least one kind of a compound selected from the group consisting of (1) a TGFβ/SMAD pathway inhibitor, (2) a casein kinase 1 inhibitor, (3) a cAMP inducer and (4) a MEK/ERK pathway inhibitor.
-
公开(公告)号:US20180195043A1
公开(公告)日:2018-07-12
申请号:US15900930
申请日:2018-02-21
发明人: Kenta YAMAMOTO , Tsunao KISHIDA , Toshiro YAMAMOTO , Osam MAZDA
IPC分类号: C12N5/077 , C12N5/074 , C12N5/0735
CPC分类号: C12N5/0654 , C12N5/0606 , C12N5/0696 , C12N5/10 , C12N15/09
摘要: An object of the present invention is to provide a method for generating an osteoblast that is applicable to repair of a bone defect due to various tumors, injuries, surgeries, etc. and to treatment for bone resorption typified by a periodontal disease, bone fracture, osteoporosis, etc., and that has a low risk of carcinogenesis. Provided as a means for achieving this object is a method for generating an osteoblast from a somatic cell of a mammal, the method comprising introducing Oct9 gene or an expression product thereof into the somatic cell.
-
公开(公告)号:US20240124842A1
公开(公告)日:2024-04-18
申请号:US18394085
申请日:2023-12-22
发明人: Kenta YAMAMOTO , Tsunao KISHIDA , Yoshihiro SOWA , Toshiro YAMAMOTO , Osam MAZDA
IPC分类号: C12N5/077 , C12N5/0775
CPC分类号: C12N5/0656 , C12N5/0653 , C12N5/0654 , C12N5/0655 , C12N5/0658 , C12N5/0663 , C12N2501/15
摘要: Provided is a method of preparing a somatic cell including converting a differentiated somatic cell of a mammal to other somatic cell by culturing the differentiated somatic cell in a medium for inducing differentiation of the somatic cell other than the differentiated somatic cell in the presence of a TGF-β pathway inhibitor.
-
公开(公告)号:US20240084258A1
公开(公告)日:2024-03-14
申请号:US18517402
申请日:2023-11-22
发明人: Kenta YAMAMOTO , Tsunao Kishida , Toshiro Yamamoto , Osam Mazda
CPC分类号: C12N5/0653 , A61K35/35 , C12N2501/01 , C12N2501/15 , C12N2501/30 , C12N2501/727 , C12N2501/999 , C12N2506/1307
摘要: The present invention aims to provide a brown adipocyte and a generation method thereof, a transplantation material containing a brown adipocyte, a prophylactic agent or therapeutic agent containing a brown adipocyte for various diseases and conditions, and use thereof. Provided is a method for generating a brown adipocyte, including converting a differentiated somatic cell of a mammal to a brown adipocyte by culturing the somatic cell in a medium in the presence of at least one kind of a compound selected from the group consisting of (1) a TGFβ/SMAD pathway inhibitor, (2) a casein kinase 1 inhibitor, (3) a cAMP inducer and (4) a MEK/ERK pathway inhibitor.
-
6.
公开(公告)号:US20170037374A1
公开(公告)日:2017-02-09
申请号:US15304287
申请日:2015-04-17
发明人: Kenta YAMAMOTO , Tsunao KISHIDA , Toshiro YAMAMOTO , Osam MAZDA
IPC分类号: C12N5/077
CPC分类号: C12N5/0654 , A61K35/32 , C12N2500/30 , C12N2501/01 , C12N2501/065 , C12N2501/36 , C12N2501/39 , C12N2501/72 , C12N2501/727 , C12N2506/1307
摘要: An object of the present invention is to provide a method for preparing osteoblasts that are applicable, without causing risk of canceration, to bone defect repair or to the treatment of bone resorption, fracture, osteoporosis, or the like. To solve this problem, the present invention provides a method for preparing osteoblasts, the method comprising culturing mammal differentiated somatic cells in a medium in the presence of at least one compound selected from the group consisting of (1) statin compounds, (2) casein kinase 1 inhibitors, (3) cAMP inducers, and (4) histone methyltransferase inhibitors, to convert the somatic cells into osteoblasts.
摘要翻译: 本发明的目的是提供一种制备可以不引起癌变风险的成骨细胞制备骨缺损修复或骨吸收,骨折,骨质疏松症等的治疗方法。 为了解决这个问题,本发明提供了一种制备成骨细胞的方法,该方法包括在至少一种选自(1)他汀类化合物,(2)酪蛋白的化合物的存在下,在培养基中培养哺乳动物分化的体细胞 激酶1抑制剂,(3)cAMP诱导剂和(4)组蛋白甲基转移酶抑制剂,将体细胞转化成成骨细胞。
-
公开(公告)号:US20160160180A1
公开(公告)日:2016-06-09
申请号:US14906948
申请日:2014-07-24
发明人: Kenta YAMAMOTO , Tsunao KISHIDA , Toshiro YAMAMOTO , Osam MAZDA
CPC分类号: C12N5/0654 , C12N15/85 , C12N2501/60 , C12N2501/603 , C12N2506/1307 , C12N2510/00
摘要: The present invention relates to: a method of preparing an osteoblast from a somatic cell of a mammal, the method including introducing a bone-related gene or an expression product thereof and a reprogramming-related gene or an expression product thereof, or introducing a reprogramming-related gene or an expression product thereof independently into the somatic cell, the bone-related gene including at least one kind selected from the group consisting of Runx2 (R), Osterix (O), and Dlx5 (D), the reprogramming-related gene including at least one kind selected from the group consisting of Oct family, c-Myc (M), L-Myc (L), Klf family, Lin-28, and Sox2; and an osteoblast prepared by the method.
摘要翻译: 本发明涉及一种从哺乳动物体细胞制备成骨细胞的方法,所述方法包括引入骨相关基因或其表达产物和重编程相关基因或其表达产物,或引入重编程 相关基因或其表达产物独立地进入体细胞,所述骨相关基因包括选自Runx2(R),Osterix(O)和Dlx5(D)中的至少一种,重编程相关基因 包括选自Oct族,c-Myc(M),L-Myc(L),Klf家族,Lin-28和Sox2中的至少一种的基因; 和通过该方法制备的成骨细胞。
-
-
-
-
-
-